$3.62
0.020.56%
Pre-Market: Jan 21, 9:11 AM EDT
Comments
Loading...
Genfit (NASDAQ:GNFT) Stock Quotes, Forecast and News Summary
Genfit Stock (NASDAQ: GNFT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genfit (GNFT) stock?
You can purchase shares of Genfit (NASDAQ:GNFT) through any online brokerage.
Who are Genfit (GNFT) competitors?
Other companies in Genfit’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for Genfit (GNFT) stock?
Genfit has a consensus price target of $11.50.
What is the current price for Genfit (GNFT)?
The stock price for Genfit (NASDAQ: GNFT) is $3.62 last updated January 21, 2025 at 9:11 AM EST.
Does Genfit (GNFT) pay a dividend?
There are no upcoming dividends for Genfit.
When is Genfit (NASDAQ:GNFT) reporting earnings?
Genfit’s FY earnings are confirmed for Thursday, April 3, 2025.
Is Genfit (GNFT) going to split?
There is no upcoming split for Genfit.
What sector and industry does Genfit (GNFT) operate in?
Genfit is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.